A new software could enable a common laboratory device to virtually separate a whole-blood sample into its different cell types and detect medically important gene-activity changes specific to any one of those cell types.
The search for a drug to replace morphinea highly effective pain reliever but one that is associated with a variety of troublesome side effectsmay be greatly accelerated thanks to a recent discovery by scientists at Albany Medical College and the state Wadsworth Center Laboratories.
Allergic reactions to peanuts could one day be as mild as hayfever, say Deakin University researchers who have established that peanut proteins form ''super allergens."
Researchers at MIT and Rockefeller University have successfully grown hepatitis C virus in otherwise healthy liver cells in the laboratory, an advance that could allow scientists to develop and test new treatments for the disease.
Titanium dioxide (TiO2) nanoparticles, found in everything from cosmetics to sunscreen to paint to vitamins, caused systemic genetic damage in mice, according to a comprehensive study conducted by researchers at UCLAs Jonsson Comprehensive Cancer Center.
NASA is preparing to fly a small satellite about the size of a loaf of bread that could help scientists better understand how effectively drugs work in space.
The National Institute of Standards and Technology (NIST) has developed a new certified reference material that can be an important quality assurance tool for measuring the amounts of vitamins, carotenoids, and trace elements in dietary supplements.
In a study published by Nature Biotechnology Mount Sinai Hospital researchers have unveiled a new technology tool that analyzes breast cancer tumors to determine a patient's best treatment options.
Healthcare consumers, benefits managers, and even government officials are using the internet to buy unapproved prescription drugs illegally, according to a report to be published in the International Journal of Electronic Healthcare.
David P. Friedman, Ph.D., professor of physiology and pharmacology at Wake Forest University School of Medicine, says that until the 1980s, the scientific community did a very poor job of communicating with anyone beyond their own campuses. That, he